Renowned Speakers
David H. Van Thiel
University Medical Center, USA, USA
Dimitar tonev
Senior medical director, UK, UK
Antonio Iannetti
University “La Sapienza†Roma, Italy, Italy
Céline Tiffon
University Hospital Bern, Switzerland, Switzerland
Fong-Fong Chu
Henan University of Science and Technology, USA, USA
Bashar Attar
Rush University Medical Center, USA, USA
Jay-lin Jane
Iowa State University USA, USA
Pierluigi Fracasso
Secretary of the European Society of Primary Care Gastroenterology, Italy, Italy
Recommended Global Gastroenterology Webinars & Conferences
Asia Pacific & Middle East
HEPATITIS 2025
Welcome Message
We are honoured and thrilled to welcome you all to the “8th International Congress on Viral Hepatitis” scheduled on March 10-11, 2025 at Paris, France, with the theme “Advancements in Hepatitis Diagnostics and Screening”
It is an opportunity to network with Doctors, professors, scientists, Specialists, educationalists, renowned speakers, researchers, and students from all over the world who have interest in sharing their research experience and practical knowledge within the arena of Gastroenterology and Liver diseases to a most exciting and memorable scientific meeting to announce and witness the recent scientific and technological advancements in Gastroenterology and Hepatology.
About Conference
The 8th International Congress on Viral Hepatitis invites all the participants across the globe to attend and share their insights and convey recent complications and advancements and in the field of Gastroenterology follows the theme “Advancements in Hepatitis Diagnostics and Screening” which will be held on March 10-11, 2025 at Paris, France.
HEPATITIS 2025 offers an opportunity to meet and make new contacts in relevant fields of Gastroenterology, Hepatology, Diabetes, Obesity, Nutrition and Health Care. The new form of innovations and researches get encouraged and providing an opportunity to the persons who are attending to the conference. It allows delegates to have issues addressed on Gastroenterology and Hepatology by recognized global experts who are up to date with the latest developments in the respective field and provide information on new innovations and technologies.
HEPATITIS 2025 unites the worldwide pioneers who are involved in the arena of Gastroenterology and Hepatology to explore their research work in the conference. It provides a great chance to collaborate with global business delegates and researchers and it is all set to be adorned by world renowned speakers.
Tracks
Participation/Presentation Options
Oral presentation: Oral Presentations may include the topics from researches, theoretical, professional or private practices in a concise manner. Individuals with personal experience are also welcome to present personal experiences or narratives which help others in everyday life. Speakers with a 30-minute slot should plan to speak for 20-25 minutes, and Keynote speakers should plan to speak for 40-45 minutes, with the remaining time to be used for questions and discussion by the Session Chair.
Workshop: For workshop presenters also, the topic of the talk will be the same as an Oral presentation with more specialized techniques and detailed demonstration. The generalized time duration for a workshop presentation is about 45-50 minutes. Interested participants can join with their respective team and present the workshop with their research coordinators with special group waivers on registration.
Poster presentation: Student Poster Competition will be organized at the Hepatitis 2025 conference is to encourage students and recent graduates to present their original research. Presenters will be given about 5-7 minutes to present the poster including questions and answers. Judges may ask questions during the evaluation of the presentation. This is an opportunity for young scientists to learn about the recent findings of their peers to increase their capacity as multidisciplinary researchers. Poster displays will be in hard copy format of 1x1 M long.
For more details regarding Poster Presentation and Judging Criteria view Poster Presentation Guidelines.
Webinar: The webinar presentation is designed for those interested attendees who cannot join in person due to schedule conflicts or other obligations. In this option, the presenter may record the presentation and their presentation will be presented in the Webinar presentation session.
E-Poster: e-Poster is also similar to the webinar presentation. In this session, their presentation will be published in the form of a poster in the conference website and the presenter abstract will be published in the conference souvenir and journal with DOI.
Exhibition: Hepatitis 2025 has the opportunity to exhibit the products and services from commercial and non-commercial organizations like Drug manufacturers, Clinical Trial Sites, Management Consultants, Chemists, Pharmacists, Business delegates and Equipment Manufacturers.
To know more about exhibitor booth details and benefits visit WHY TO EXHIBIT WITH US?
Send your queries to contact@globalconferencemeet.com
Advertisement: The conference program is a valuable resource that all attendees refer again and again as they navigate the conference. Advertising in the conference program is a great way to market and can help you secure long term business.
Send your proposal to contact@globalconferencemeet.com to know the available advertisement options and prices
Sponsor Liver Disease 2025
Premium Sponsorship package
Additional Sponsorship package
Mail the program manager at contact@globalconferencemeet.com or WhatsApp on (+44 7418315935) to know more about the sponsorship packages.
Market Analysis
HEPATITIS 2025 is the best platform for all recognized/ under- recognized scholastics in the field of Liver, Gastroenterology, Hepatology, Health specialists, analysts, educational scientists, Industry researchers, scientists to exchange about research and developments in grounds of Gastroenterology. The main focus of this meeting is to invigorate and globalize new thoughts and researches for treatment and to determine the current market for proceeding towards future of Gastro medicine, operational devices and diagnostics, with an accentuation on new technology that will be advantageous in the field of Gastroenterology and Hepatology.
The global gastrointestinal therapeutics market size was valued at USD 37.6 billion in 2022 and is expected to expand at a compound annual growth rate (CAGR) of 3.3% from 2023 to 2030. The increasing prevalence of gastrointestinal disorders such as IBS, Crohn’s disease, and ulcerative colitis and the rising demand for gastrointestinal (GI) drugs are the major factors driving the market growth. Moreover, the surge in R&D efforts by pharmaceutical companies to develop novel GI drugs and increasing product approvals are expected to enhance market growth during the forecast period.
According to the GI Alliance data from February 2021, it is estimated that around 20 million Americans suffer from chronic digestive diseases and over 62 million Americans are diagnosed with gastrointestinal diseases annually and the incidence of gastrointestinal disorders rises with age. Moreover, as per data published by the International Foundation for Gastrointestinal Disorders, Inc. (IFFGD), the prevalence of GERD is 18-28% in North America, 23% in South America and 9-26% in Europe. Thus, the high prevalence of gastrointestinal diseases is likely to drive market growth in the coming years.
To Collaborate Scientific Professionals around the World
Conference Date March 10-11, 2025
For Sponsors & Exhibitors
Speaker Opportunity
Useful Links
Supported By
All accepted abstracts will be published in respective Conference Series International Journals.
Abstracts will be provided with Digital Object Identifier by